Mersana Therapeutics, Inc. Interest Expense Nonoperating
Mersana Therapeutics, Inc. reported Interest Expense Nonoperating of $394.00 thousand for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-11-14.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpenseNonoperating · last filed 2025-11-14
- Mersana Therapeutics, Inc. interest expense nonoperating for the quarter ending 2025-09-30 was $394.00K, a 60.04% decline year-over-year.
- Mersana Therapeutics, Inc. interest expense nonoperating for the quarter ending 2025-06-30 was $674.00K, a 31.43% decline year-over-year.
- Mersana Therapeutics, Inc. interest expense nonoperating for the quarter ending 2025-03-31 was $775.00K, a 22.65% decline year-over-year.
- Mersana Therapeutics, Inc. interest expense nonoperating for the quarter ending 2024-12-31 was $903.00K, a 13.84% decline year-over-year.
- Mersana Therapeutics, Inc. interest expense nonoperating for fiscal 2024 was $3.87M, a 4.89% decline from fiscal 2023.
- Mersana Therapeutics, Inc. interest expense nonoperating for fiscal 2023 was $4.07M, a 22.39% increase from fiscal 2022.
- Mersana Therapeutics, Inc. interest expense nonoperating for fiscal 2022 was $3.33M.
| Period end | Interest Expense Nonoperating 3 month | Interest Expense Nonoperating 6 month | Interest Expense Nonoperating 9 month | Interest Expense Nonoperating 12 month |
|---|---|---|---|---|
| 2025-09-30 | $394.00K 10-Q · filed 2025-11-14 | $1.07M derived: sum of 2 quarters · filed 2025-11-14 | $1.84M 10-Q · filed 2025-11-14 | $2.75M derived: sum of 4 quarters · filed 2025-11-14 |
| 2025-06-30 | $674.00K 10-Q · filed 2025-08-13 | $1.45M 10-Q · filed 2025-08-13 | $2.35M derived: sum of 3 quarters · filed 2025-08-13 | $3.34M derived: sum of 4 quarters · filed 2025-11-14 |
| 2025-03-31 | $775.00K 10-Q · filed 2025-05-15 | $1.68M derived: sum of 2 quarters · filed 2025-05-15 | $2.66M derived: sum of 3 quarters · filed 2025-11-14 | $3.65M derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-12-31 | $903.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $1.89M derived: sum of 2 quarters · filed 2025-11-14 | $2.87M derived: sum of 3 quarters · filed 2025-11-14 | $3.87M 10-K · filed 2025-03-03 |
| 2024-09-30 | $986.00K 10-Q · filed 2025-11-14 | $1.97M derived: sum of 2 quarters · filed 2025-11-14 | $2.97M 10-Q · filed 2025-11-14 | $4.02M derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | $983.00K 10-Q · filed 2025-08-13 | $1.99M 10-Q · filed 2025-08-13 | $3.03M derived: sum of 3 quarters · filed 2025-08-13 | $4.05M derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | $1.00M 10-Q · filed 2025-05-15 | $2.05M derived: sum of 2 quarters · filed 2025-05-15 | $3.07M derived: sum of 3 quarters · filed 2025-05-15 | $4.09M derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | $1.05M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $2.06M derived: sum of 2 quarters · filed 2025-03-03 | $3.09M derived: sum of 3 quarters · filed 2025-03-03 | $4.07M 10-K · filed 2025-03-03 |
| 2023-09-30 | $1.02M 10-Q · filed 2024-11-13 | $2.04M derived: sum of 2 quarters · filed 2024-11-13 | $3.02M 10-Q · filed 2024-11-13 | |
| 2023-06-30 | $1.02M 10-Q · filed 2024-08-13 | $2.01M 10-Q · filed 2024-08-13 | ||
| 2022-12-31 | $3.33M 10-K · filed 2025-03-03 |